Reference data : LOINC code

Filter


Clear filter

Results
104,672 results found
Loinc Number Component Property System Time aspect ScaleType MethodType Relat_nms loincStatus Long Common name answerList chngType DefinitionDescription dtLastCh exactCmspy exampleUnits exmplAnswers externalCopyrightNotice formula hl7FieldSubfieldId InpcPercentage ipccUnits loincClass loincFinal loincNum mapTo methodTyp molarMass naaccrId orderObs panelElements reference scope setRoot shortName source surveyQuestSrc surveyQuestText unitsRequired acssym relatedNames2 VersionLastChanged VersionFirstRelease ValidHL7AttachmentRequest PanelType AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14571-4 17-Hydroxyprogesterone SRat Urine 24H Qn     ACTIVE 17-Hydroxyprogesterone [Moles/time] in 24 hour Urine   MIN DefinitionDescription     nmol/24 H             CHEM   14571-4         Both       0 17OHP 24h Ur-sRate       Y   1 day; 17-alpha-hydroxyprogesterone; 17-Hydroxypregn-4-en-3,20-dione; 17-hydroxy-progest; 17-OH Progesterone; 17OHP; 17-OHP; 17-P; 24 hours; 24HR; Chemistry; Hydroxyproges; Hydroxyprogstron; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.42 1.0k               nmol/(24.h)       0
14572-2 17-Ketosteroids SRat Urine 24H Qn     ACTIVE 17-Ketosteroids [Moles/time] in 24 hour Urine   MIN DefinitionDescription     umol/d             CHEM   14572-2         Both       0 17KS 24h Ur-sRate       Y   1 day; 17KS; 17-KS; 24 hours; 24HR; Chemistry; Ketosteroid; Ketostroids; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.4 1.0k               umol/(24.h)       0
14573-0 5-Hydroxyindoleacetate SRat Urine 24H Qn     ACTIVE 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine   MIN DefinitionDescription     umol/d             CHEM   14573-0         Both       0 5OH-indoleacetate 24h Ur-sRate       Y   1 day; 24 hours; 24HR; 5HIA; 5HIAA; 5-HIAA; 5-Hydroxy indoleacetate; 5-hydroxyindoleacetic acid; 5OH-indoleacetate; Chemistry; Hydroxyindoacet; Oncology; QNT; Quan; Quant; Quantitative; Serotonin metabolite; sRate; Substance Rate; Tumor marker; UA; UR; Urn 2.73 1.0k               umol/(24.h)       0
14574-8 8-Hydroxyamoxapine SCnc Ser/Plas Pt Qn     ACTIVE 8-Hydroxyamoxapine [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14574-8         Both       0 8OH-Amoxapine SerPl-sCnc       Y   8-Hydroxy amoxapine; 8OH-Amoxapine; Amoxapine metabolite; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               umol/L       0
14575-5 Blood group antibody investigation Imp Plas/RBC Pt Nom     ACTIVE Blood group antibody investigation [Interpretation] in Plasma or RBC   MIN DefinitionDescription                   BLDBK   14575-5         Both       0 Bld gp Ab Invest PlasRBC-Imp           Ab; Bld gp Ab Invest; Bld gp Ab Scn; BLOOD BANK; Erythrocytes; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Pl; Plasma; PlasRBC; Plsm; Point in time; Random; Red blood cells; Red blood corpusles; UniversalLabOrders 2.73 1.0k                       0
14576-3 Blood group antibody investigation Imp Plas/RBC Pt Nom Senior review   ACTIVE Blood group antibody investigation [Interpretation] in Plasma or RBC by Senior review   MIN DefinitionDescription                   BLDBK   14576-3   Senior review     Observation       0 Bld gp Ab Invest PlasRBC Sr Rev-Imp           Ab; Bld gp Ab Invest; Bld gp Ab Scn; BLOOD BANK; Erythrocytes; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; Nominal; Pl; Plasma; PlasRBC; Plsm; Point in time; Random; Red blood cells; Red blood corpusles; Sr Rev 2.73 1.0k                       0
14577-1 ABO & Rh group Type Bld^Donor Pt Nom     ACTIVE ABO and Rh group [Type] in Blood from Donor   MIN DefinitionDescription                   BLDBK   14577-1         Observation       0 ABO + Rh Bld Donr           ABO + Rh; ABO group and Rh type; ABO+Rh Gp; Blood; BLOOD BANK; D phenotyping; D typing; Donr; Hematology; Heme; Nominal; Point in time; Random; Rh phenotyping; Rh typing; Typ; WB; Whole blood 2.72 1.0k                       0
14578-9 ABO group Type Bld^BPU Pt Nom     ACTIVE ABO group [Type] in Blood from Blood product unit   MIN DefinitionDescription                   BLDBK   14578-9         Observation       0 ABO Group Bld BPU           Blood; BLOOD BANK; Blood product unit; Blood Product Unit (Pack); Hematology; Heme; Nominal; Point in time; Random; Typ; WB; Whole blood 2.73 1.0k                       0
14579-7 ABO group Type Bld^Donor Pt Nom     ACTIVE ABO group [Type] in Blood from Donor   MIN DefinitionDescription                   BLDBK   14579-7         Observation       0 ABO Group Bld Donr           Blood; BLOOD BANK; Donr; Hematology; Heme; Nominal; Point in time; Random; Typ; WB; Whole blood 2.73 1.0k                       0
1458-9 Creatinine^pre 500 ug dexamethasone PO 2.5 day low dose q6h MCnc Urine 24H Qn     ACTIVE Creatinine [Mass/volume] in 24 hour Urine --pre 500 ug dexamethasone PO 2.5 day low dose q6h   MIN DefinitionDescription     g/L; mcg/mL; mg/dL; mg/mL             CHAL   1458-9         Observation       0 Creat pre 500 ug Dex 24h Ur-mCnc       Y   1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Decadron; Dexameth; Dexone; Hexadrol; Level; lo dose; Mass Concentration; mcg; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn 2.4 1               mg/dL       0
14580-5 ABO group Type Bld^Newborn Pt Nom     ACTIVE ABO group [Type] in Blood from Newborn   MIN DefinitionDescription                   BLDBK   14580-5         Both       0 ABO Group Bld NB           Blood; BLOOD BANK; Hematology; Heme; NB; New born; Nominal; Point in time; Random; Typ; WB; Whole blood 2.73 1.0k                       0
14581-3 Acetaminophen SCnc Ser/Plas Pt Qn     ACTIVE Acetaminophen [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             DRUG/TOX   14581-3         Both       0 APAP SerPl-sCnc       Y   ACET; Acetamidophenol; Acetaminoph; Acetominophen; Addiction; APAP; c209; C55; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Hepatology; Hydroxyacetanilide; Illicit; Level; Liver; N-(4-Hydroxyphenyl)acetanilide; N-Acetyl-p-aminophenol; p-Acetamidophenol; Paracetamol; p-Hydroxyacetanilide; Pl; Plasma; Plsm; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tylenol; u209 2.73 1.0k               umol/L       0
14582-1 Acetone SCnc Ser/Plas Pt Qn     ACTIVE Acetone [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     mmol/L             DRUG/TOX   14582-1         Both       0 Acetone SerPl-sCnc       Y   2-propanone; DRUG/TOXICOLOGY; Drugs; Ketone bodies; Level; Me2CO; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               mmol/L       0
14583-9 Acidity.titratable MCnc Gast fld Pt Qn     DISCOURAGED Acidity.titratable [Mass/volume] in Gastric fluid   MIN DefinitionDescription                   CHEM   14583-9         Both       0 Titratable Acidity Gast-mCnc       Y   Chemistry; GAST; Gastric contents; Gastric fluid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Titratable Acidity 2.44 1.0k       AssociatedObservations EXTERNAL_COPYRIGHT_LINK HL7_ATTACHMENT_STRUCTURE CONSUMER_NAME EXAMPLE_UCUM_UNITS STATUS_REASON STATUS_TEXT CHANGE_REASON_PUBLIC COMMON_TEST_RANK COMMON_ORDER_RANK
14584-7 Adenosine monophosphate.cyclic SRat Urine 24H Qn     ACTIVE Adenosine monophosphate.cyclic [Moles/time] in 24 hour Urine   MIN DefinitionDescription     umol/24 H             CHEM   14584-7         Both       0 cAMP 24h Ur-sRate       Y   1 day; 24 hours; 24HR; Adenosine 2'-Phosphate; Adenosine 3'-Phosphate; Adenosine 5'-Phosphate; Adenylic Acid; ADO; AMP; ANED; cAMP; Chemistry; CMP; Medication stress; Phosphaden; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.42 1.0k               umol/(24.h)       0
14585-4 Albumin/Creatinine SRto Urine Pt Qn     ACTIVE Albumin/Creatinine [Molar ratio] in Urine   MIN DefinitionDescription     mmol/mol creatinine             CHEM   14585-4         Both       0 Albumin/Creat Ur-sRto       Y   Alb; Chemistry; CR; Crea; Creat; Kidney; Nephrology; Point in time; Protein.albumin; QNT; Quan; Quant; Quantitative; Random; Renal; Scrto; Substance concentration ratio; Substance ratio; UA; UCr; UR; Urn 2.42 1.0k               mmol/mol{creat}       0
14586-2 Aldosterone SCnc Ser/Plas Pt Qn     ACTIVE Aldosterone [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     pmol/L             CHEM   14586-2         Both       0 Aldost SerPl-sCnc       Y   Chemistry; Endocrine; Endocrinology; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.73 1.0k               pmol/L       0
14587-0 Aldosterone SRat Urine 24H Qn     ACTIVE Aldosterone [Moles/time] in 24 hour Urine   MIN DefinitionDescription     nmol/24 H             CHEM   14587-0         Both       0 Aldost 24h Ur-sRate       Y   1 day; 24 hours; 24HR; Chemistry; Endocrine; Endocrinology; QNT; Quan; Quant; Quantitative; sRate; Substance Rate; UA; UR; Urn 2.73 1.0k               nmol/(24.h)       0
14588-8 Alkaline phosphatase isoenzymes Imp Ser/Plas Pt Nom     ACTIVE Alkaline phosphatase isoenzymes [Interpretation] in Serum or Plasma   MIN DefinitionDescription                   CHEM   14588-8         Observation       0 ALP Isos SerPl-Imp           Alk; Alk phos; Alkaline phos; Alkaline phosphatase.total; ALKP; ALP; ALP Isos; AP; Chemistry; Hepatology; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; ISO; Isoen; Isoenzyme; Liver; Nominal; Phos; Phosphtase; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1.0k                       0
14589-6 Amylase isoenzymes Imp Ser/Plas Pt Nom     ACTIVE Amylase isoenzymes [Interpretation] in Serum or Plasma   MIN DefinitionDescription                   CHEM   14589-6         Observation       0 Amylase Isos SerPl-Imp           Alpha amylase; Ams; Amyl; Amylase Isos; Chemistry; Diastase; Gastro; Gastroenterology; GI; Impression; Impression/interpretation of study; Impressions; Interp; Interpretation; ISO; Isoamy; Isoamylase; Isoen; Isoenzyme; k87; Nominal; Pl; Plasma; Plsm; Point in time; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR 2.73 1.0k                       0
1459-7 Creatinine^pre 2 mg dexamethasone PO 2.5 day high dose q6h MCnc Urine 24H Qn     ACTIVE Creatinine [Mass/volume] in 24 hour Urine --pre 2 mg dexamethasone PO 2.5 day high dose q6h   MIN DefinitionDescription     g/L; mcg/mL; mg/dL; mg/mL             CHAL   1459-7         Observation       0 Creat pre 2 mg Dex high 24h Ur-mCnc       Y   1 day; 24 hours; 24HR; Before; c350; CHEMISTRY.CHALLENGE TESTING; CR; Crea; Creat; Decadron; Dexameth; Dexone; Hexadrol; hi dose; II; Level; Mass concentration; pre 2 mg Dex high; QNT; Quan; Quant; Quantitative; UA; UCr; UR; Urn 2.73 1               mg/dL       0
14590-4 Alpha tocopherol SCnc Ser/Plas Pt Qn     ACTIVE Alpha tocopherol [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     umol/L             CHEM   14590-4         Both       0 A-Tocopherol Vit E SerPl-sCnc       Y   Alfa; A-Tocopherol Vit E; Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tocopherols; Vit E; Vitamin E 2.73 1.0k               umol/L       0
14591-2 ALPRAZolam SCnc Ser/Plas Pt Qn     ACTIVE ALPRAZolam [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/L             DRUG/TOX   14591-2         Both       0 Alpraz SerPl-sCnc       Y   DRUG/TOXICOLOGY; Drugs; Level; Niravam; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Xanax 2.34 1.0k               nmol/L       0
14592-0 Aluminum SCnc Urine 24H Qn     ACTIVE Aluminum [Moles/volume] in 24 hour Urine   MIN DefinitionDescription     nmol/L             DRUG/TOX   14592-0         Both       0 Aluminum 24h Ur-sCnc       Y   1 day; 24 hours; 24HR; AL; Aluminium; DRUG/TOXICOLOGY; Drugs; Level; QNT; Quan; Quant; Quantitative; Substance Concentration; UA; UR; Urn 2.34 1.0k               nmol/L       0
14593-8 Aluminum SCnc Ser/Plas Pt Qn     ACTIVE Aluminum [Moles/volume] in Serum or Plasma   MIN DefinitionDescription     nmol/L             DRUG/TOX   14593-8         Both       0 Aluminum SerPl-sCnc       Y   AL; Aluminium; DRUG/TOXICOLOGY; Drugs; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration 2.34 1.0k               nmol/L       0
104,672 results found